Edwards Lifesciences Corp Stock Price Prediction
| EW Stock | USD 71.35 0.72 1.00% |
Oversold Vs Overbought
52
Oversold | Overbought |
Quarterly Earnings Growth 7.161 | EPS Estimate Next Quarter 0.62 | EPS Estimate Current Year 2.5299 | EPS Estimate Next Year 2.4702 | Wall Street Target Price 76.605 |
Using Edwards Lifesciences hype-based prediction, you can estimate the value of Edwards Lifesciences Corp from the perspective of Edwards Lifesciences response to recently generated media hype and the effects of current headlines on its competitors.
Edwards Lifesciences Corp Hype to Price Pattern
Investor biases related to Edwards Lifesciences' public news can be used to forecast risks associated with an investment in Edwards. The trend in average sentiment can be used to explain how an investor holding Edwards can time the market purely based on public headlines and social activities around Edwards Lifesciences Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Edwards Lifesciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Edwards Lifesciences.
The fear of missing out, i.e., FOMO, can cause potential investors in Edwards Lifesciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Edwards because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Edwards Lifesciences after-hype prediction price | USD 71.37 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Edwards |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edwards Lifesciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Edwards Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Edwards Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Edwards Lifesciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Edwards Lifesciences Estimiated After-Hype Price Volatility
In the context of predicting Edwards Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Edwards Lifesciences' historical news coverage. Edwards Lifesciences' after-hype downside and upside margins for the prediction period are 69.81 and 72.93, respectively. We have considered Edwards Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Edwards Lifesciences is very steady at this time. Analysis and calculation of next after-hype price of Edwards Lifesciences Corp is based on 3 months time horizon.
Edwards Lifesciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Edwards Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Edwards Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Edwards Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 1.56 | 0.02 | 0.02 | 5 Events / Month | 7 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
71.35 | 71.37 | 0.03 |
|
Edwards Lifesciences Hype Timeline
As of December 1, 2024 Edwards Lifesciences Corp is listed for 71.35. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of -0.02. Edwards is anticipated to increase in value after the next headline, with the price projected to jump to 71.37 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 0.03%, whereas the daily expected return is currently at 0.07%. The volatility of related hype on Edwards Lifesciences is about 503.23%, with the expected price after the next announcement by competition of 71.33. The company generated the yearly revenue of 6 B. Reported Net Income was 1.4 B with gross profit of 4.3 B. Allowing for the 90-day total investment horizon the next anticipated press release will be in about 5 days. Check out Edwards Lifesciences Basic Forecasting Models to cross-verify your projections.Edwards Lifesciences Related Hype Analysis
Having access to credible news sources related to Edwards Lifesciences' direct competition is more important than ever and may enhance your ability to predict Edwards Lifesciences' future price movements. Getting to know how Edwards Lifesciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Edwards Lifesciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MDT | Medtronic PLC | 1.42 | 7 per month | 0.00 | (0.14) | 1.73 | (1.80) | 5.69 | |
| ABT | Abbott Laboratories | 0.54 | 8 per month | 0.86 | (0.04) | 1.40 | (1.29) | 5.90 | |
| BSX | Boston Scientific Corp | 0.85 | 9 per month | 0.63 | 0.07 | 1.58 | (1.19) | 5.62 | |
| ZBH | Zimmer Biomet Holdings | 0.63 | 9 per month | 0.00 | (0.09) | 1.66 | (1.83) | 9.43 | |
| SYK | Stryker | (4.17) | 10 per month | 0.86 | 0.02 | 1.77 | (1.73) | 4.70 | |
| DXCM | DexCom Inc | (0.37) | 8 per month | 1.45 | 0.02 | 4.17 | (2.43) | 8.17 | |
| PODD | Insulet | 4.34 | 11 per month | 0.64 | 0.17 | 2.87 | (1.68) | 12.33 | |
| TNDM | Tandem Diabetes Care | (1.77) | 9 per month | 0.00 | (0.21) | 4.24 | (4.60) | 12.63 | |
| ALGN | Align Technology | (4.26) | 10 per month | 2.16 | (0.04) | 4.22 | (3.31) | 11.73 |
Edwards Lifesciences Additional Predictive Modules
Most predictive techniques to examine Edwards price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Edwards using various technical indicators. When you analyze Edwards charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Edwards Lifesciences Predictive Indicators
The successful prediction of Edwards Lifesciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Edwards Lifesciences Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Edwards Lifesciences based on analysis of Edwards Lifesciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Edwards Lifesciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Edwards Lifesciences's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 46.38 | 47.41 | 50.87 | 60.19 | PTB Ratio | 13.84 | 7.95 | 6.96 | 4.82 |
Story Coverage note for Edwards Lifesciences
The number of cover stories for Edwards Lifesciences depends on current market conditions and Edwards Lifesciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Edwards Lifesciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Edwards Lifesciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Edwards Lifesciences Short Properties
Edwards Lifesciences' future price predictability will typically decrease when Edwards Lifesciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Edwards Lifesciences Corp often depends not only on the future outlook of the potential Edwards Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Edwards Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 609.4 M | |
| Cash And Short Term Investments | 1.6 B |
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.